The company said, "The company expects fourth quarter organic revenue growth of 4.5% to 5.0%, which brackets current Street consensus and raises the company’s full fiscal year organic growth outlook. If foreign currency exchange rates as of the beginning of February hold, fourth quarter revenue would be unfavorably affected by approximately $165 million to $215 million."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MDT:
- Medtronic’s (NYSE:MDT) Decent Q3 Results Kindle Hope
- Medtronic reports third quarter fiscal 2023 financial results
- Medtronic receives CE Mark for extravascular defibrillator system
- Medtronic put volume heavy and directionally bearish
- Apple names Medtronic’s Surface as Chief People Officer, Bloomberg says
